Charles River Laboratories (CRL): are the analysts right?

Jun 17, 26

▲ Overweight · 🎯$220

Price at call : $182.34 — upside +21%

Today : $228.68 — upside -4%

🎯 on CRL : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)

in progress (365j)
matures : Jun 17, 27

CLSA

May 29, 26

▲ Outperform · 🎯$219

Price at call : $180.71 — upside +21%

Today : $228.68 — upside -4%

🎯 on CRL : no call matured yet · 📊 unranked overall

in progress (365j)
matures : May 29, 27

May 8, 26

▲ Overweight · 🎯$220

Price at call : $168.46 — upside +31%

Today : $228.68 — upside -4%

🎯 on CRL : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)

in progress (365j)
matures : May 8, 27

May 8, 26

▲ Outperform · 🎯$220

Price at call : $168.46 — upside +31%

Today : $228.68 — upside -4%

🎯 on CRL : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)

in progress (365j)
matures : May 8, 27

Apr 14, 26

▲ Overweight · 🎯$210

Price at call : $180.56 — upside +16%

Today : $228.68 — upside -8%

🎯 on CRL : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)

in progress (365j)
matures : Apr 14, 27

Apr 13, 26

■ Neutral neutral · not a buy · 🎯$160

Price at call : $179.31 — gap to target -11%

Today : $228.68 — gap to target -30%

🎯 on CRL : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)

in progress (365j)
matures : Apr 13, 27

UBS ↗

Feb 25, 26

■ Neutral neutral · not a buy · 🎯$175

Price at call : $175.46 — gap to target -0%

Today : $228.68 — gap to target -23%

🎯 on CRL : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)

in progress (365j)
matures : Feb 25, 27

TD Cowen ↗

Feb 20, 26

▲ Buy · 🎯$235

Price at call : $163.52 — upside +44%

Today : $228.68 — upside +3%

🎯 on CRL : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)

in progress (365j)
matures : Feb 20, 27

Feb 20, 26

■ Neutral neutral · not a buy · 🎯$175

Price at call : $163.52 — gap to target +7%

Today : $228.68 — gap to target -23%

🎯 on CRL : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)

in progress (365j)
matures : Feb 20, 27

Feb 19, 26

▲ Overweight · 🎯$200

Price at call : $168.92 — upside +18%

Today : $228.68 — upside -13%

🎯 on CRL : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)

in progress (365j)
matures : Feb 19, 27

Feb 19, 26

▲ Outperform · 🎯$200

Price at call : $164.24 — upside +22%

Today : $228.68 — upside -13%

🎯 on CRL : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)

in progress (365j)
matures : Feb 19, 27

Citigroup ↗

Jan 16, 26

▲ Buy · 🎯$265

Price at call : $218.19 — upside +21%

Today : $228.68 — upside +16%

🎯 on CRL : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)

in progress (365j)
matures : Jan 16, 27

Jan 13, 26

▲ Outperform · 🎯$260

Price at call : $216.39 — upside +20%

Today : $228.68 — upside +14%

🎯 on CRL : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)

in progress (365j)
matures : Jan 13, 27

Dec 18, 25

■ Neutral neutral · not a buy · 🎯$200

Price at call : $193.85 — gap to target +3%

Today : $228.68 — gap to target -13%

🎯 on CRL : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)

in progress (365j)
matures : Dec 18, 26

Dec 15, 25

▲ Overweight · 🎯$215

Price at call : $195.22 — upside +10%

Today : $228.68 — upside -6%

🎯 on CRL : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)

in progress (365j)
matures : Dec 15, 26

Dec 15, 25

■ Neutral neutral · not a buy · 🎯$190

Price at call : $195.22 — gap to target -3%

Today : $228.68 — gap to target -17%

🎯 on CRL : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)

in progress (365j)
matures : Dec 15, 26

Nov 11, 25

■ Equal-Weight neutral · not a buy · 🎯$185

Price at call : $171.5 — gap to target +8%

Today : $228.68 — gap to target -19%

🎯 on CRL : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)

in progress (365j)
matures : Nov 11, 26

TD Cowen ↗

Nov 10, 25

▲ Buy · 🎯$197

Price at call : $173.5 — upside +14%

Today : $228.68 — upside -14%

🎯 on CRL : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)

in progress (365j)
matures : Nov 10, 26

Nov 6, 25

■ Neutral neutral · not a buy · 🎯$165

Price at call : $168.05 — gap to target -2%

Today : $228.68 — gap to target -28%

🎯 on CRL : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)

in progress (365j)
matures : Nov 6, 26

Nov 6, 25

▲ Overweight · 🎯$210

Price at call : $168.05 — upside +25%

Today : $228.68 — upside -8%

🎯 on CRL : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)

in progress (365j)
matures : Nov 6, 26

Baird ↗

Nov 6, 25

▲ Outperform · 🎯$199

Price at call : $170.88 — upside +16%

Today : $228.68 — upside -13%

🎯 on CRL : no call matured yet · 📊 on Health : 52.3% · +7.1% (287 calls)

in progress (365j)
matures : Nov 6, 26

Oct 17, 25

■ Neutral neutral · not a buy · 🎯$174

Price at call : $178.52 — gap to target -3%

Today : $228.68 — gap to target -24%

🎯 on CRL : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)

in progress (365j)
matures : Oct 17, 26

William Blair ↗

Oct 6, 25

▲ Outperform

🎯 on CRL : 100% (1 call matured) · 📊 on Health : 65.4% · +5.6% (26 calls)

in progress (365j)
matures : Oct 6, 26

Oct 3, 25

▲ Outperform · 🎯$200

Price at call : $174.95 — upside +14%

Today : $228.68 — upside -13%

🎯 on CRL : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)

in progress (365j)
matures : Oct 3, 26

Oct 2, 25

▲ Overweight · 🎯$195

Price at call : $175.36 — upside +11%

Today : $228.68 — upside -15%

🎯 on CRL : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)

in progress (365j)
matures : Oct 2, 26

Jefferies ↗

Sep 9, 25

▲ Buy · 🎯$195

Price at call : $157.38 — upside +24%

Today : $228.68 — upside -15%

🎯 on CRL : no call matured yet · 📊 on Health : 50.5% · +4.5% (376 calls)

in progress (365j)
matures : Sep 9, 26

Aug 8, 25

▲ Outperform · 🎯$190

Price at call : $148.74 — upside +28%

Today : $228.68 — upside -17%

🎯 on CRL : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)

in progress (365j)
matures : Aug 8, 26

Aug 7, 25

■ Neutral neutral · not a buy · 🎯$160

Price at call : $148.74 — gap to target +8%

Today : $228.68 — gap to target -30%

🎯 on CRL : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)

in progress (365j)
matures : Aug 7, 26

Aug 7, 25

■ Equal-Weight neutral · not a buy · 🎯$165

Price at call : $149.78 — gap to target +10%

Today : $228.68 — gap to target -28%

🎯 on CRL : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)

in progress (365j)
matures : Aug 7, 26

Jul 9, 25

▲ Outperform · 🎯$180

Price at call : $158.97 — upside +13%

Today : $228.68 — upside -21%

🎯 on CRL : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)

in progress (365j)
matures : Jul 9, 26

Citigroup ↗

Jul 9, 25

▲ Buy · 🎯$200

Price at call : $158.97 — upside +26%

Today : $228.68 — upside -13%

🎯 on CRL : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)

in progress (365j)
matures : Jul 9, 26

Redburn Atlantic

May 23, 25

▲ Buy · 🎯$182

Price at call : $136.73 — upside +33%

Today : $228.68 — upside -20%

Expected +33% · Actual +15% · Reason (≥ +15%) : ✗ No

🎯 on CRL : 100% (1 call matured) · 📊 unranked overall

+14.6%

stock +15% · XLV +14%

May 8, 25

■ Equal-Weight neutral · not a buy · 🎯$155

Price at call : $138.79 — gap to target +12%

Today : $228.68 — gap to target -32%

🎯 on CRL : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)

in progress (365j)
matures : May 8, 26

Baird ↗

May 8, 25

■ Neutral neutral · not a buy · 🎯$140

Price at call : $141.36 — gap to target -1%

Today : $228.68 — gap to target -39%

🎯 on CRL : no call matured yet · 📊 on Health : 52.3% · +7.1% (287 calls)

in progress (365j)
matures : May 8, 26

Apr 10, 25

■ Equal-Weight neutral · not a buy · 🎯$145

Price at call : $99.75 — gap to target +45%

Today : $228.68 — gap to target -37%

🎯 on CRL : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)

in progress (365j)
matures : Apr 10, 26

Apr 9, 25

■ Neutral neutral · not a buy · 🎯$155

Price at call : $139.07 — gap to target +11%

Today : $228.68 — gap to target -32%

🎯 on CRL : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)

in progress (365j)
matures : Apr 9, 26

Goldman Sachs ↗

Mar 21, 25

■ Neutral neutral · not a buy · 🎯$170

Price at call : $167.28 — gap to target +2%

Today : $228.68 — gap to target -26%

🎯 on CRL : 100% (1 call matured) · 📊 on Health : 50.8% · +2.0% (240 calls)

in progress (365j)
matures : Mar 21, 26

Citigroup ↗

Mar 4, 25

■ Neutral neutral · not a buy · 🎯$175

Price at call : $164.31 — gap to target +7%

Today : $228.68 — gap to target -23%

🎯 on CRL : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)

in progress (365j)
matures : Mar 4, 26

Redburn Atlantic

Mar 3, 25

■ Neutral neutral · not a buy · 🎯$188

Price at call : $163.5 — gap to target +15%

Today : $228.68 — gap to target -18%

🎯 on CRL : 100% (1 call matured) · 📊 unranked overall

in progress (365j)
matures : Mar 3, 26

Feb 20, 25

■ Neutral neutral · not a buy · 🎯$165

Price at call : $163.02 — gap to target +1%

Today : $228.68 — gap to target -28%

🎯 on CRL : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)

in progress (365j)
matures : Feb 20, 26

Baird ↗

Feb 20, 25

■ Neutral neutral · not a buy · 🎯$173

Price at call : $162.25 — gap to target +7%

Today : $228.68 — gap to target -24%

🎯 on CRL : no call matured yet · 📊 on Health : 52.3% · +7.1% (287 calls)

in progress (365j)
matures : Feb 20, 26

Feb 20, 25

■ Equal-Weight neutral · not a buy · 🎯$160

Price at call : $162.25 — gap to target -1%

Today : $228.68 — gap to target -30%

🎯 on CRL : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)

in progress (365j)
matures : Feb 20, 26

Feb 18, 25

■ Equal-Weight neutral · not a buy · 🎯$166

Price at call : $154.39 — gap to target +8%

Today : $228.68 — gap to target -27%

🎯 on CRL : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)

in progress (365j)
matures : Feb 18, 26

Feb 5, 25

■ Equal-Weight neutral · not a buy · 🎯$184

Price at call : $165.87 — gap to target +11%

Today : $228.68 — gap to target -20%

🎯 on CRL : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)

in progress (365j)
matures : Feb 5, 26

Feb 3, 25

■ Neutral neutral · not a buy · 🎯$175

Price at call : $163.12 — gap to target +7%

Today : $228.68 — gap to target -23%

🎯 on CRL : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)

in progress (365j)
matures : Feb 3, 26

Goldman Sachs ↗

Jan 23, 25

▲ Buy · 🎯$190

Price at call : $164.97 — upside +15%

Today : $228.68 — upside -17%

Expected +15% · Actual +35% · Reason (≥ +15%) : ✓ Yes

🎯 on CRL : 100% (1 call matured) · 📊 on Health : 50.8% · +2.0% (240 calls)

+34.8%

stock +35% · XLV +10%

William Blair ↗

Jan 22, 25

■ Market Perform neutral · not a buy

🎯 on CRL : 100% (1 call matured) · 📊 on Health : 65.4% · +5.6% (26 calls)

in progress (365j)
matures : Jan 22, 26

UBS ↗

Jan 17, 25

■ Neutral neutral · not a buy · 🎯$185

Price at call : $163.5 — gap to target +13%

Today : $228.68 — gap to target -19%

🎯 on CRL : no call matured yet · 📊 on Health : 52.1% · +3.4% (340 calls)

in progress (365j)
matures : Jan 17, 26

William Blair ↗

Jan 14, 25

▲ Outperform

Actual +28% · Reason (≥ +15%) : ✓ Yes

🎯 on CRL : 100% (1 call matured) · 📊 on Health : 65.4% · +5.6% (26 calls)

+28.5%

stock +28% · XLV +12%